利必妥合併療法（因治隆注射液一千五百萬單位/毫升合併瑞比達膠
Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
RIBAVIRIN;;INTERFERON ALPHA- 2B
Available from:
先靈葆雅企業股份有限公司 臺北市中山區民權東路三段４號９樓 (36547709)
ATC code:
L03AB05
Pharmaceutical form:
注射劑
Composition:
INTERFERON ALPHA- 2B (0818000710) 15000000IU (I; RIBAVIRIN (0818000800) 200MG
Units in package:
盒裝
Class:
製 劑
Prescription type:
限由醫師使用
Manufactured by:
SCHERING-PLOUGH (BRINNY) COMPANY INNISHANNON, CO. CORK, IE
Therapeutic area:
interferon alfa-2b
Therapeutic indications:
１．曾經使用 Ａ─ＩＮＴＥＲＦＥＲＯＮ單一療法治療後又復發的慢性Ｃ型肝炎。２．首次接受治療的慢性Ｃ型肝炎。
Product summary:
註銷日期: 2010/05/31; 註銷理由: 屆期未申請展延; 有效日期: 2006/06/18; 英文品名: REBETRON COMBINATION THERAPY PAK (INTRON A 15 MIU/ML PLUS REBETOL 200MG/CAP)
Authorization status:
已註銷
Authorization date:
2001-06-18
